Morgan Keegan Maintains Outperform on Emeritus (ESC)

Morgan Keegan is out with its report today on Emeritus ESC, maintaining Outperform. In a note to clients, Morgan Keegan writes, "We believe that Emeritus is positioned to enhance operations through marketing, pricing, and cost containment. Our Outperform rating is based on our view that Emeritus can grow both internally and externally despite a challenging operating environment through stable or rising occupancy, pricing growth, operating cost containment, and accretive asset additions." Shares of ESC closed Tuesday at $24.69, up 1.23% from Monday's close.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorAnalyst RatingsEmeritusHealth CareHealth Care FacilitiesMorgan Keegan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!